Growth Metrics

Core Laboratories (CLB) Total Non-Current Liabilities (2022 - 2025)

Core Laboratories' Total Non-Current Liabilities history spans 4 years, with the latest figure at $296.0 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 6.88% year-over-year to $296.0 million; the TTM value through Dec 2025 reached $296.0 million, down 6.88%, while the annual FY2025 figure was $296.0 million, 6.88% down from the prior year.
  • Total Non-Current Liabilities reached $296.0 million in Q4 2025 per CLB's latest filing, up from $292.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $373.9 million in Q4 2022 to a low of $292.5 million in Q3 2025.
  • Average Total Non-Current Liabilities over 4 years is $329.1 million, with a median of $327.8 million recorded in 2024.
  • The largest YoY upside for Total Non-Current Liabilities was 5.68% in 2025 against a maximum downside of 9.66% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $373.9 million in 2022, then dropped by 8.55% to $342.0 million in 2023, then dropped by 7.06% to $317.8 million in 2024, then fell by 6.88% to $296.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Total Non-Current Liabilities are $296.0 million (Q4 2025), $292.5 million (Q3 2025), and $312.9 million (Q2 2025).